FDA Inspection
Innovative Intrathecal Solutions, Inc. dba Innovative Compounding PharmacyInnovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy – FDA Inspection, Oct 26, 2021
Record Details
This FDA Inspection record concerns Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy, with an inspection on October 26, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 26, 2021
- Product Type
- Drugs
View Company Profile
ID · b38b6100-9c52-4f51-b1c4-e803cd6420a3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1155775
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- Hazardous drugs, prevention of cross-contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 20, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 18, 2017 | Not classified | Los Angeles District Office | Drug Quality Assurance |
Other documents for Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.